Gwen Melincoff
Director/Board Member at GAIN THERAPEUTICS, INC.
Net worth: 521 944 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Heffernan | M | 59 | 22 years | |
| Anish Bhatnagar | M | 56 | 18 years | |
| Matthias Alder | M | 59 | 3 years | |
| Joseph Ciaffoni | M | 53 | 7 years | |
| Eyal Rubin | M | 48 | 5 years | |
| Gianluca Fuggetta | M | 35 | 2 years | |
| Dror Bashan | M | 57 | 5 years | |
| Ernest Mario | M | 85 | 17 years | |
| Shirley Kuhlmann | F | 40 | 6 years | |
| Donald E. Nickelson | M | 91 |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 21 years |
| David B. Matias | M | - |
Vodia Capital LLC
 Vodia Capital LLC Investment ManagersFinance Part of Robertson Stephens Wealth Management LLC, Vodia Capital LLC provides investment advisory services. The private company is based in Concord, MA. The company was founded by David B. Matias. David B. Matias has been the CEO since incorporation. Vodia Capital was acquired by Robertson Stephens Wealth Management LLC on December 13, 2022. | - |
| Dov Goldstein | M | 56 | 3 years | |
| Claude Nicaise | M | 71 | 3 years | |
| Birgitte Volck | M | 61 | 5 years | |
| Matthew Pauls | M | 53 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Scott Sudduth | M | - | 6 years | |
| Shmuel Ben Zvi | M | 64 | 2 years | |
| Neil McFarlane | M | 51 | 2 years | |
| Scott Dreyer | M | 52 | 6 years | |
| Daniel Schneider | M | - | 6 years | |
| Rita Balice-Gordon | M | 63 | 4 years | |
| Manolo Bellotto | M | 53 | 6 years | |
| Andrew Sinclair | M | 52 | 6 years | |
| Yaron Naos | M | 60 | 20 years | |
| Eliot Forster | M | 58 | 1 years | |
| John Freund | M | 70 | 10 years | |
| Eric Richman | M | 63 | 4 years | |
| Gino Santini | M | 66 | 12 years | |
| Claude H. Nash | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 24 years |
| Bill Harris | M | 65 | 10 years | |
| Johanna Holldack | M | - | 7 years | |
| Hans-Peter Hasler | M | 68 | 3 years | |
| Jeffrey Riley | M | 61 | 5 years | |
| Pol Boudes | M | 67 | 5 years | |
| Khalid Islam | M | 67 | 7 years | |
| John Fallon | M | 76 | 8 years | |
| Chaime Orlev | M | 53 | 7 years | |
| Garen Bohlin | M | 76 | 9 years | |
| Aharon Schwartz | M | 80 | 10 years | |
| Amos Bar Shalev | M | 71 | 16 years | |
| Maja Bergmann | F | - | 5 years | |
| Christopher James | M | - | 1 years | |
| Elena Cubero-Jorda | F | - | - | |
| Marissa Samuels | F | - | 2 years | |
| Fellous Yael | F | - | 2 years | |
| Colleen Tupper | F | 48 | 3 years | |
| Charles Horn | M | - | 2 years | |
| Arun Padmanabhan | M | - | 7 years | |
| Meredith S. Manning | F | - | - | |
| Lauren Budesheim | F | - | - | |
| Patricia Hirano | F | 58 | 7 years | |
| Neil M. Cowen | M | - | 7 years | |
| James Mackaness | M | 60 | 5 years | |
| Kristen Yen | F | 55 | 18 years | |
| Geoffrey Coy | M | - | 5 years | |
| Bart J. Dunn | M | 65 | 5 years | |
| David P. Geoghegan | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 20 years |
| Thomas Smith | M | 63 | 2 years | |
| Gina Balderas | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Dougherty | M | 66 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 11 years |
| Bruce Peacock | M | 72 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 3 years |
| Ambrose Bailey | M | 60 | - | |
| Zeev Bronfeld | M | 71 | 17 years | |
| Matthew Gantz | M | 59 |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania. | 7 years |
| Kjetil Hestdal | M | 64 | 21 years | |
| Yoseph Shaaltiel | M | 71 | 27 years | |
| Michael Metzger | M | 53 | - | |
| Saadia Ozeri | M | 54 | 13 years | |
| Samuel Rubinstein | M | 59 | 2 years | |
| Raul Chertkoff | M | - | - | |
| Anders Tuv | M | 46 | - | |
| William Taylor | M | - | 7 years | |
| Robert Harrell | M | - |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Jonathan R. Wolter | M | 73 | 2 years | |
| Ruth Wolfson | M | 77 | 14 years | |
| Alison B. Fleming | M | 49 | 19 years | |
| Howard Mayer | M | 62 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 6 years |
| Anne Hovi Worsøe | F | 60 | - | |
| Synne Hermansen Røine | F | 45 | 6 years | |
| Jan Hendrik Egberts | M | 65 | 6 years | |
| Michael DeGeorge | M | - | 7 years | |
| Paul Brannelly | M | 51 | 6 years | |
| Gil Efron | M | 57 | 6 years | |
| George V. Hager | M | 68 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | - |
| William Burns | M | 76 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | 8 years |
| Jeffrey Cooper | M | 68 | 1 years | |
| Andrew Fromkin | M | 58 | 1 years | |
| Avri Havron | M | 76 | 8 years | |
| Stuart J. M. Collinson | M | 64 | 3 years | |
| Eckard Weber | M | 73 | 1 years | |
| Patrick Heron | M | 53 | 1 years | |
| Ian Clements | M | 55 | 1 years | |
| Dennis Podlesak | M | 66 | 1 years | |
| Laurent Fischer | M | 60 | 1 years | |
| Theodore Schroeder | M | 69 | 5 years | |
| Tom Edward Pike | M | 64 | 6 years | |
| Pierre Legault | M | 63 | 2 years | |
| Itzhak Krinsky | M | 71 | 2 years | |
| Mahendra Shah | M | 79 | 1 years | |
| Asaf Yosef Frumerman | M | 39 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 68 | 68.00% |
| Israel | 22 | 22.00% |
| Norway | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gwen Melincoff
- Personal Network
